InvestorsHub Logo
Followers 54
Posts 1023
Boards Moderated 0
Alias Born 03/15/2013

Re: None

Monday, 12/30/2013 12:18:37 PM

Monday, December 30, 2013 12:18:37 PM

Post# of 158400
BMSN/Regen BioPharma Timeline for IND Approval According to S-1/A and PRs

9/24 - Began additional efficacy tests (Estimated to last 3 months according to S-1/A)

(This is the testing the PR on 12/11 was announcing the completion of)

12/11 - Additional safety tests were already underway (Estimated to last 2 months according to S-1/A)

(This is the testing Dr. Min stated was already under way on the 12/11 PR)

2/11 - Safety tests should be completed

Depending on how long it takes Regen to submit the results and how long it takes the FDA to review the data, the review could be completed anywhere between mid February to the end of March. The S-1/A states that the company expects approval by March 31, 2014 and the initiation of Phase I Trials to begin in July 2014.

Also, the company anticipates filing of the dCellVax IND by March 31, 2014.

And as if that weren't enough, the dividend could be approved any day now.

http://www.sec.gov/Archives/edgar/data/1589150/000155479513000724/regen112013forms1a.htm

http://www.marketwired.com/press-release/regen-biopharma-announces-hemaxellerate-i-efficacy-data-animal-model-aplastic-anemia-otcqb-bmsn-1861361.htm

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.